Back to search

Peptide record

TPDB92297

B1AW Antibacterial Anticancer Hemolysis Toxicity standard
24 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB92297
B1AW
Antibacterial Anticancer Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia CancerPPD 2.0 dbACP Hemolytic2
standard
No
A 24-aa standard natural multi-activity (Antibacterial, Anticancer, Hemolysis, and other sources) peptide sequence curated from Peptipedia, CancerPPD 2.0, dbACP, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
FLPLLAGLAANFLPQIICKIARKC-NH2
Physicochemical Analysis
C123H205N31O27S2
DEHMSTWYV
L
2614.29
9.92
3
0
14
+3
-2.45
1.142
146.67
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
125
4.78
4
Residue Composition
number
4
A
1
R
1
N
0
D
2
C
0
E
1
Q
1
G
0
H
3
I
5
L
2
K
0
M
2
F
2
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 4 R: 1 N: 1 D: 0 C: 2 E: 0 Q: 1 G: 1 H: 0 I: 3 L: 5 K: 2 M: 0 F: 2 P: 2 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
24
C123H205N31O27S2
2614.29
9.92
+3
-2.45
1.142
Amidation
L
Linear
Free
Antimicrobial and Antitumor
Wuyi torrent frog, Amolops wuyiensis
Evidence Records 3 records
Evidence 1 Activity

Activity

IC50
IC50 = 33.46 µM
Anticancer
33.46 µM

Target

Prostate Cancer
PC-3
Prostate

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 = 32.15 µM
Anticancer
32.15 µM

Target

Lung Cancer
H-838
Lung

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2023
Evidence 3 Activity

Activity

IC50
IC50 = 33.56 µM
Anticancer
33.56 µM

Target

Brain Tumor
U251-MG
Brain

Assay & Model

MTT assay
24-h

Source & Reference

CancerPPD 2.0 dbACP
CancerPPD2
2023